TCRX

Tscan Therapeutics Inc

May 15 • 04:00PM ET

1.00

-0.11 -9.91 %

Healthcare • Biotechnology • USA • Micro • NASD

Peers: LYEL FATE NKTX IMRX CGEN

| Held by: VTI VXF IWC

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.96	Insider Own	15.38%	Shs Outstand	55.82M	Perf Week	-20.63%
Market Cap	65.35M	Forward P/E	-	EPS next Y	-0.97	Insider Trans	1.64%	Shs Float	55.30M	Perf Month	-7.41%
Enterprise Value	29.83M	PEG	-	EPS next Q	-0.26	Inst Own	43.87%	Short Float	1.57%	Perf Quarter	7.30%
Income	-124.31M	P/S	7.15	EPS this Y	-5.40%	Inst Trans	-7.35%	Short Ratio	1.00	Perf Half Y	-15.97%
Sales	9.14M	P/B	0.62	EPS next Y	8.35%	ROA	-46.50%	Short Interest	0.87M	Perf YTD	0.00%
Book/sh	1.61	P/C	0.51	EPS next 5Y	5.09%	ROE	-80.95%	52W High	2.57 -61.09%	Perf Year	-23.66%
Cash/sh	1.96	P/FCF	-	EPS past 3/5Y	28.66% 2.08%	ROIC	-68.29%	52W Low	0.88 13.33%	Perf 3Y	-75.19%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	-8.63% 56.92%	Gross Margin	68.48%	Volatility	8.34% 9.40%	Perf 5Y	-
Dividend TTM	-	EV/Sales	3.26	EPS Y/Y TTM	12.20%	Oper. Margin	-1408.73%	ATR (14)	0.10	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	6.65	Sales Y/Y TTM	106.65%	Profit Margin	-1360.61%	RSI (14)	37.66	Recom	1.33
Dividend Gr. 3/5Y	- -	Current Ratio	6.65	EPS Q/Q	16.19%	SMA20	-17.56%	Beta	1.05	Target Price	6.00
Payout	-	Debt/Eq	0.95	Sales Q/Q	-54.77%	SMA50	-11.11%	Rel Volume	0.97	Prev Close	1.11
Employees	142	LT Debt/Eq	0.88	Earnings	May 06 BMO	SMA200	-26.22%	Avg Volume	867.15K	Price	1.00
IPO	Jul 16, 2021	Option/Short	No / Yes	EPS/Sales Surpr.	-8.64% -60.72%	Trades		Volume	840,527	Change	-9.91%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)